US Patent Issued to Dyne Therapeutics on Oct. 14 for "Muscle targeting complexes and formulations for treating myotonic dystrophy" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,574, issued on Oct. 14, was assigned to Dyne Therapeutics Inc. (Waltham, Mass.).

"Muscle targeting complexes and formulations for treating myotonic dystrophy" was invented by Scott Hilderbrand (Waltham, Mass.), Timothy Weeden (Waltham, Mass.), John Najim (Waltham, Mass.), Stefano Zanotti (Waltham, Mass.), Romesh R. Subramanian (Framingham, Mass.), Mohammed T. Qatanani (Waltham, Mass.), Cody A. Desjardins (Waltham, Mass.), Kim Tang (Waltham, Mass.) and Brendan Quinn (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the disclosure relate to complexes and other aspects relate to formulations (e.g., aqueous, lyophilized forms) comprising...